Sugitani Masahiko, Tamura Akinori, Shimizu Yohko K, Sheikh Aleemuzzaman, Kinukawa Noriko, Shimizu Kazufumi, Moriyama Mitsuhiko, Komiyama Kazuo, Li Tian-Cheng, Takeda Naokazu, Arakawa Yasuyuki, Suzuki Koyu, Ishaque Shamsuddin M, Roy Projesh K, Raihan A S M A, Hasan Mahmud
Department of Pathology, Nihon University School of Medicine, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan.
J Gastroenterol Hepatol. 2009 Apr;24(4):599-604. doi: 10.1111/j.1440-1746.2008.05677.x. Epub 2008 Dec 1.
BACKGROUND/AIMS: Hepatitis E virus (HEV) in Bangladesh has not been adequately documented. We report HEV RNA and genotype detection in Bangladesh.
In total, 82 samples were used; 36 sporadic acute hepatitis (AH), 12 fulminant hepatitis (FH), 14 chronic liver disease (CLD) and 20 from an apparently healthy population (HP) positive for both immunoglobulin (Ig) M and IgG specific anti-HEV antibodies (anti-HEV). The male/female ratio was 61/21, ages 12-67 (mean 30.4) years. RNA was extracted, transcribed to cDNA and amplified in nt 6345-6490 (ORF2) of HEV. Nucleic and amino acid sequences were determined. Homology comparison between Bangladesh clones and other representative HEV clones and phylogenetic tree analyses were done. Relations between HEV RNA-positivity and clinical factors were analyzed.
HEV RNA was positive in 9/36 (25.0%) of AH cases, 4/12 (33.3%) FH, 3/14 (21.4%) CLD and 0/20 (0%) HP samples; total 16/82 (19.5%). Four factors correlated significantly with HEV RNA-positivity (Mann-Whitney U test); alanine aminotransferase (ALT) (P = 0.0229), aspartate aminotransferase (AST) (P = 0.0448), and titers of IgG (P = 0.0208) and IgM (P = 0.0095) specific anti-HEV. The 16 HEV clones were divided mainly into two groups, A and B, including six different cDNA sub-groups.
HEV RNA was found in sporadic AH and FH and sub-clinical CLD cases, but not in HP. HEV RNA-positivity was significantly related to values of ALT and AST and titers of IgG and IgM specific anti-HEV, with IgM specific anti-HEV showing the most significant relationship. All clones were genotype I, which is prevalent in South Asia.
背景/目的:孟加拉国的戊型肝炎病毒(HEV)尚未得到充分记录。我们报告了孟加拉国HEV RNA及基因型检测情况。
共使用了82份样本;36份散发性急性肝炎(AH)样本、12份暴发性肝炎(FH)样本、14份慢性肝病(CLD)样本以及20份来自免疫球蛋白(Ig)M和IgG特异性抗HEV抗体(抗HEV)均呈阳性的表面健康人群(HP)的样本。男女比例为61/21,年龄在12至67岁(平均30.4岁)之间。提取RNA,转录为cDNA,并在HEV的核苷酸6345 - 6490(ORF2)区域进行扩增。测定核酸和氨基酸序列。对孟加拉国克隆与其他代表性HEV克隆进行同源性比较并进行系统发育树分析。分析HEV RNA阳性与临床因素之间的关系。
AH病例中9/36(25.0%)、FH病例中4/12(33.3%)、CLD病例中3/14(21.4%)的样本HEV RNA呈阳性,HP样本中0/20(0%)呈阳性;总计16/82(19.5%)。有四个因素与HEV RNA阳性显著相关(曼-惠特尼U检验);丙氨酸转氨酶(ALT)(P = 0.0229)、天冬氨酸转氨酶(AST)(P = 0.0448)以及IgG(P = 0.0208)和IgM(P = 0.0095)特异性抗HEV的滴度。16个HEV克隆主要分为A和B两组,包括六个不同的cDNA亚组。
在散发性AH、FH和亚临床CLD病例中发现了HEV RNA,但在HP中未发现。HEV RNA阳性与ALT和AST值以及IgG和IgM特异性抗HEV滴度显著相关,其中IgM特异性抗HEV的相关性最为显著。所有克隆均为I型基因型,在南亚地区较为普遍。